Synthetic Biology
Home / Services / Synthetic Biology Chassis Development / Artificial Cell Chassis Engineering
Trusted by Leading Research & Pharma Institutions

Construction of Artificial Cell Chassis for Biosynthesis

Build next-generation synthetic biology platforms with custom artificial cell chassis. From minimal genome design to compartmentalized cell-free systems, we provide comprehensive solutions for advanced biomanufacturing and metabolic engineering applications.

Minimal Genome Design
Cell-Free Systems
Scalable Production
Learn More

Trusted by leading research and pharmaceutical institutions

Harvard
Pfizer
MIT
Roche
Stanford
Merck

Why Choose Our Platform

Minimal genome design for orthogonal systems
Cell-free expression platforms ready
Scalable from lab to industrial production
Expert consultation included

Minimal Genome Design

Streamlined chassis with reduced complexity

Cell-Free Systems

Pure biochemical synthesis platforms

Compartmentalization

Multi-compartment synthetic cells

Overview Technology Specifications Workflow Applications FAQ
Service Overview

Comprehensive Artificial Cell Chassis Solutions

Our platform combines cutting-edge minimal genome design with advanced cell-free expression systems for next-generation biomanufacturing.

Minimal Genome Design

Streamline cellular complexity through genome reduction. Remove non-essential genes to create orthogonal, predictable chassis organisms with enhanced metabolic efficiency and reduced regulatory burden.

  • Top-down genome reduction strategies
  • Bottom-up synthetic genome construction
  • JCVI-syn3A derived platforms

Cell-Free Expression Systems

Harness the power of in vitro protein synthesis without living cells. Achieve precise control over biochemical reactions, eliminate cellular toxicity constraints, and enable rapid prototyping of biosynthetic pathways.

  • PURE system optimization
  • Bacterial lysate-based CFE
  • Minimal cell-derived systems

Compartmentalization

Multi-compartment synthetic cells with artificial organelles for spatial reaction control.

Metabolic Engineering

Optimized metabolic flux toward target compounds with reduced competing pathways.

Biosafety

Natural biocontainment: minimal cells cannot survive outside lab conditions, ideal for pharmaceutical safety.

Ready to Build Your Synthetic Biology Platform?

Get a customized quote for your artificial cell chassis project.

Technology Platform

Advanced Chassis Construction Technologies

State-of-the-art platforms for minimal genome design and cell-free synthetic biology.

Genome Reduction

Advanced genome editing combined with high-throughput screening to identify and remove non-essential genes while preserving core cellular functions.

CRISPR/Cas9 Transposon Mutagenesis

Cell-Free Expression

Optimized cell-free protein synthesis systems derived from minimal genomes. Eliminate cellular constraints for predictable, controllable biochemical production.

PURE System Bacterial Lysate

Compartmentalization

Multi-compartment synthetic cells with artificial organelles. Engineer spatial organization for sequential reactions and metabolic channeling.

GUVs Polymersomes

Quality Control

NGS Whole genome sequencing verification
MS Mass spectrometry protein verification
FACS High-throughput phenotypic screening
COA Certificate of Analysis included

Platform Options

MIN Minimal genome chassis
CFE Cell-free expression systems
SYN Synthetic cell construction
CMP Compartmentalized platforms
Specifications

Flexible Platforms for Diverse Needs

Comprehensive specifications to meet your research requirements.

Parameter Minimal Genome Cell-Free Systems Synthetic Cells
Genome Size 0.5 - 1.2 Mb N/A Custom
Gene Count 473 - 900 genes Defined components Application-dependent
Expression Yield In vivo production Up to mg/mL Variable
Host Organisms E. coli, Mycoplasma Defined systems GUV, Liposome
Scalability Lab to industrial Reaction scale Custom
Workflow

Streamlined Process from Design to Delivery

Our proven workflow ensures quality and efficiency at every stage.

1

Consultation

Project requirements and chassis selection

2

Design

Genome design and pathway planning

3

Construction

Genome editing and system assembly

4

Verification

NGS QC and functional assays

5

Delivery

Strain delivery with documentation

Applications

Diverse Applications Across Biotechnology

Our chassis platforms support research and development in multiple fields.

Biopharmaceutical Manufacturing

Engineered cell chassis for efficient production of therapeutic proteins, vaccines, and biologics. Minimal genomes reduce impurity profiles and simplify downstream processing.

  • Recombinant vaccine antigen production
  • Therapeutic protein expression
  • Cytokine and antibody fragment production
  • Live biotherapeutic applications
99%
Purity achievable with minimal chassis

Metabolic Engineering

Redirect metabolic flux toward target compounds using optimized chassis. Reduced genome complexity eliminates competing pathways and improves product yields.

  • Biofuels and bioplastics production
  • Flavors and fragrance biosynthesis
  • Industrial enzyme production
  • Commodity chemicals synthesis
3x
Higher specific productivity vs wild-type hosts
Streamlined downstream processing

Synthetic Biology Research

Fundamental studies on minimal life, gene function, and cellular organization. Cell-free systems provide controlled environments for mechanistic studies.

  • Origins of life research
  • Gene essentiality studies
  • Artificial cell construction
  • Metabolic pathway analysis
473
Minimal gene set available
Testimonials

What Our Clients Say

Trusted by researchers worldwide for quality and reliability.

"The minimal genome chassis exceeded our expectations. The reduced complexity significantly improved our metabolic engineering outcomes. Highly recommended for any synthetic biology project."

S
Senior Scientist
Biotechnology Company

"Excellent technical support and fast turnaround. The cell-free system was exactly what we needed for our protein production project. Will definitely use again for our next grant."

P
Research Director
Academic Research Institution

"The compartmentalized synthetic cell platform opened new research directions for our lab. The quality of the GUV preparations was outstanding. Professional service throughout."

L
Lead Researcher
Pharmaceutical Company
Scientific Literature

Scientific Foundation

Our platform is backed by peer-reviewed research.

285 Citations

Synthetic Cells: From Simple Bio-Inspired Modules to Sophisticated Integrated Systems

Guindani C, da Silva LC, Cao S, Ivanov T, Landfester K. Angew Chem Int Ed. 2022.

Comprehensive review of bottom-up synthetic biology approaches for constructing artificial cells and organelles with advanced functionalities.

View DOI
89 Citations

Cell-Free Expression System Derived from a Near-Minimal Synthetic Bacterium

Sakai A, Jonker AJ, Nelissen FHT, et al. ACS Synth Biol. 2023.

First functional CFE system derived from JCVI-syn3A using nitrogen decompression lysis, enabling advances in bottom-up synthetic biology.

View DOI
67 Citations

Minimal Out-of-Equilibrium Metabolism for Synthetic Cells: A Membrane Perspective

Bailoni E, Partipilo M, Coenradij J, et al. ACS Synth Biol. 2023.

Review of minimal metabolism design strategies for synthetic cells including energy provision, homeostasis, transport, and membrane expansion.

View DOI
112 Citations

Bottom-Up Assembly of Synthetic Cells with a DNA Cytoskeleton

Jahnke K, et al. ACS Nano. 2022.

De novo assembly of artificial DNA-based cytoskeletons inside GUVs with light-controlled reversible assembly and bundling.

View DOI
45 Citations

Advancing Biomimetic Functions of Synthetic Cells through Compartmentalized Cell-Free Protein Synthesis

Powers J, Jang Y. Biomacromolecules. 2023.

Integration of CFPS mechanisms into vesicle platforms for synthetic cells with genetic circuits, sensing, and artificial organelles.

View DOI
FAQ

Frequently Asked Questions

Find answers to common questions about our service.

An artificial cell chassis is a streamlined cellular or cell-like system engineered to serve as a platform for synthetic biology applications. This includes minimal genome organisms with reduced genetic complexity, cell-free expression systems, and compartmentalized synthetic cells. These platforms offer predictable behavior, enhanced biosafety, and optimized metabolic efficiency for biomanufacturing.
Minimal genome chassis offer several advantages including: reduced metabolic burden, elimination of competing pathways for improved product yields, enhanced genetic stability, simplified regulatory approval due to reduced complexity, and improved predictability for pathway engineering. JCVI-syn3A with only 473 genes exemplifies the ultimate minimal bacterial chassis.
Cell-free expression systems bypass living cells entirely by isolating the molecular machinery needed for transcription and translation. This eliminates constraints from cellular toxicity, membrane transport limitations, and regulatory networks. Cell-free systems enable rapid prototyping, precise reaction control, and direct synthesis of products that would be harmful to live cells.
Our synthetic cell platforms support diverse applications including: biopharmaceutical manufacturing (vaccines, therapeutic proteins), metabolic engineering (biofuels, chemicals, enzymes), sustainable biomanufacturing, live biotherapeutics, fundamental synthetic biology research, and origins of life studies. Compartmentalized systems are particularly valuable for multi-step enzymatic cascade reactions.
Project timelines vary based on complexity: minimal genome chassis development takes 8-16 weeks, cell-free system optimization 4-8 weeks, and synthetic cell construction 6-12 weeks. Initial consultation and design phase typically takes 1-2 weeks. Scale-up and fermentation development adds 8-16 weeks depending on requirements.
Yes, our minimal genome chassis and engineered strains are designed for scalability from laboratory research to industrial fermentation. We provide comprehensive scale-up support including process optimization, fermentation parameter development, and tech transfer documentation. Cell-free systems can be scaled to reaction volumes as needed.
Every project includes comprehensive quality control: whole genome sequencing verification, mass spectrometry-based protein confirmation, phenotypic screening via FACS, growth kinetics characterization, and full documentation with Certificate of Analysis. Custom QC protocols can be developed for specific regulatory requirements.
We work with a range of platforms including E. coli, yeast (Saccharomyces cerevisiae, Pichia pastoris), lactic acid bacteria, Mycoplasma-based minimal cells (JCVI-syn3A, JCVI-syn3B), and artificial cell systems (GUVs, polymersomes, proteinosomes). Selection depends on your application requirements.

Ready to Start Your Project?

Get a customized quote for your Artificial Cell Chassis Engineering project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation

Recommended Services

· Phage Chassis Engineering
· Insects Chassis Engineering
· Bacterial Chassis Engineering
· Plant Chassis Engineering
· Algal Chassis Engineering
· Protozoa Chassis Engineering

Related Resources

· Cost and Efficiency Analysis of CRlSPR-Cas9 Knockout Services in Mice and Cell Lines
· Validating CRISPR Knockouts: Best Practices for qPCR, Sequencing, and Functional Assays
· Step-by-Step Guide to Generating CRISPR Knockout Cell Lines for Research
Quick Links

Home

Products

Services

About Us

Contact Us

Follow Us
CONTACT US

USA

Tel:

Email:

Japan

Tel:

Email:

Korea

Tel:

Email:

Copyright © 2026 CD Biosynsis. All rights reserved.